etesevimab

Eli Lilly and Co (NYSE: LLY)’s antibody treatments have received an emergency use authorization from the United States Food and Drug Administration. What Happened: The federal regulator issued the EUA for the two drugs, bamlanivimab and etesevimab, to be administered together for the...